ascopubs.org

Identification of SNVs via targeted comprehensive genome profiling in patients with brain cancer.

Overcoming temozolomide resistance in glioblastoma through selective inhibition of phosphoinositide 3-kinase catalytic subunit. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I.
ascopubs.org

Identification of novel actionable SNVs using targeted comprehensive genome profiling in patients with sarcoma.

Microsatellite instability in sarcomas: Which tests are ideal for diagnosis, and a systematic review. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not ...
Futurism

New Method Can Detect Cancerous Mutations in Individual Cells

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Half ...
Labroots

SNVs to Large Structural Variation: Capturing nucleotide through inter-chromosomal variants through a powerful three-dimensional data type

Within the clinical arena, the oncology community has led the way in the early adoption of next generation sequencing. NGS is in widespread use in clinical cancer research and is now beginning to help ...